PedAM
Pediatric Disease Annotations & Medicines
| Disease | sarcoma |
| Phenotype | C0235974|pancreatic cancer |
| Sentences | 1 |
| PubMedID- 25994202 | Clinically, th-302 has been investigated in several early stage trials [8-11] and is currently being evaluated in phase iii trials in soft-tissue sarcoma in combination with doxorubicin and pancreatic cancer in combination with gemcitabine (nct01440088 and nct01746979, respectively). |
Page: 1